These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33602084)

  • 21. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
    Kimura T; Singh S; Tanaka N; Umemura T
    Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
    Ezhilarasan D; Sokal E; Najimi M
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of serum extracellular vesicles in liver fibrosis.
    Chen L; Chen R; Kemper S; Cong M; You H; Brigstock DR
    J Extracell Vesicles; 2018; 7(1):1461505. PubMed ID: 29696080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brg1 promotes liver fibrosis via activation of hepatic stellate cells.
    Li H; Lan J; Han C; Guo K; Wang G; Hu J; Gong J; Luo X; Cao Z
    Exp Cell Res; 2018 Mar; 364(2):191-197. PubMed ID: 29427621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research progress of extracellular vesicles in hepatic fibrosis].
    Tao CY; Guo JS; Shi YH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):407-410. PubMed ID: 31357753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice.
    Eguchi A; Yan R; Pan SQ; Wu R; Kim J; Chen Y; Ansong C; Smith RD; Tempaku M; Ohno-Machado L; Takei Y; Feldstein AE; Tsukamoto H
    J Mol Med (Berl); 2020 Jul; 98(7):1021-1034. PubMed ID: 32556367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.
    Kong D; Zhang F; Zhang Z; Lu Y; Zheng S
    Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells.
    Arroyo N; Villamayor L; Díaz I; Carmona R; Ramos-Rodríguez M; Muñoz-Chápuli R; Pasquali L; Toscano MG; Martín F; Cano DA; Rojas A
    JCI Insight; 2021 Dec; 6(23):. PubMed ID: 34699385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells.
    Choi JS; Kim JK; Yang YJ; Kim Y; Kim P; Park SG; Cho EY; Lee DH; Choi JW
    Pharmacol Res; 2015 Dec; 102():176-83. PubMed ID: 26453959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
    Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7.
    Yu K; Li N; Cheng Q; Zheng J; Zhu M; Bao S; Chen M; Shi G
    J Mol Med (Berl); 2018 Jan; 96(1):65-74. PubMed ID: 29051972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis.
    Luo J; Zhang P; Zhao T; Jia M; Yin P; Li W; Zhang ZR; Fu Y; Gong T
    ACS Nano; 2019 Apr; 13(4):3910-3923. PubMed ID: 30938986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NS5ATP13 Promotes Liver Fibrogenesis Via Activation of Hepatic Stellate Cells.
    Li Y; Liu S; Han M; Lu H; Wang Q; Zhang Y; Tursun K; Li Z; Feng S; Cheng J
    J Cell Biochem; 2017 Aug; 118(8):2463-2473. PubMed ID: 28133777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
    Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis.
    Chen H; Gan Q; Yang C; Peng X; Qin J; Qiu S; Jiang Y; Tu S; He Y; Li S; Yang H; Tao L; Peng Y
    J Transl Med; 2019 Aug; 17(1):280. PubMed ID: 31443720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.
    Zhu J; Zhang Z; Zhang Y; Li W; Zheng W; Yu J; Wang B; Chen L; Zhuo Q; Chen L; Zhang J; Liu J
    Biochem Biophys Res Commun; 2018 Jan; 496(1):176-183. PubMed ID: 29307832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages.
    Lee HS; Shin HS; Choi J; Bae SJ; Wee HJ; Son T; Seo JH; Park JH; Kim SW; Kim KW
    Int J Oncol; 2016 Oct; 49(4):1407-14. PubMed ID: 27498767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.